{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:37:38Z","timestamp":1761766658875},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,3,22]],"date-time":"2003-03-22T00:00:00Z","timestamp":1048291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00345-003-0322-7","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:27:10Z","timestamp":1576121230000},"page":"37-42","source":"Crossref","is-referenced-by-count":14,"title":["The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study"],"prefix":"10.1007","volume":"21","author":[{"given":"C. J.","family":"Tyrrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Kaisary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Melezinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,22]]},"reference":[{"key":"0322_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s001980050101","volume":"8","author":"Benmalek","year":"1998","unstructured":"Benmalek A, Sabatier JP (1998) Comparison and cross-calibration of DXA systems: ODX-240 and Sophos L-XRA versus Hologic QDR-4500 for spinal bone mineral measurement. Translation of a reference database. Osteoporos Int 8:570\u2013577","journal-title":"Osteoporos Int"},{"key":"0322_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S8756-3282(97)00012-4","volume":"20","author":"Broulik","year":"1997","unstructured":"Broulik PD, St\u00e1rka L (1997) Effect of antiandrogens Casodex and epitestosterone on bone composition in mice. Bone 20:473\u2013475","journal-title":"Bone"},{"key":"0322_CR3","first-page":"S220","volume":"14","author":"Calero","year":"1999","unstructured":"Calero JA, Diaz-Curiel M, de al Piedra C (1999) Bicalutamide (Casodex) treatment does not produce bone effects in male Wistar rats. J Bone Min Res 14 (Suppl 1):S220","journal-title":"J Bone Min Res"},{"key":"0322_CR4","first-page":"mortality","volume":"over","author":"Congress","year":"1993","unstructured":"Congress of the United States (1993) Hip fracture outcomes in people aged 50 and over: mortality, service use, expenditures and long-term functional impairment. Washington DC. Office of Technology Assessment, Congress of the United States. US Department of Commerce publication NTIS PB94107653","journal-title":"Hip fracture outcomes in people aged 50 and"},{"key":"0322_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","volume":"2","author":"Cooper","year":"1992","unstructured":"Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285\u2013289","journal-title":"Osteoporos Int"},{"key":"0322_CR6","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/S0002-9343(97)90022-X","volume":"103","author":"Cooper","year":"1997","unstructured":"Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103(2A):12S\u201319S","journal-title":"Am J Med"},{"key":"0322_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","volume":"163","author":"Daniell","year":"2000","unstructured":"Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT (2000) Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163:181\u2013186","journal-title":"J Urol"},{"key":"0322_CR8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-5347(01)65165-6","volume":"157","author":"Daniell","year":"1997","unstructured":"Daniell HW (1997) Osteoporosis after orchiectomy for prostate cancer. J Urol 157:439\u2013444","journal-title":"J Urol"},{"key":"0322_CR9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1359\/jbmr.1998.13.10.1587","volume":"13","author":"De","year":"1998","unstructured":"De Laet CEDH, van Hout BA, Burger H, Weel AE, Hofman A, Pols HA (1998) Hip fracture risk in elderly men and women: validation in the Rotterdam study. J Bone Min Res 13:1587\u20131593","journal-title":"J Bone Min Res"},{"key":"0322_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1561::AID-CNCR11>3.0.CO;2-Z","volume":"83","author":"Diamond","year":"1998","unstructured":"Diamond T, Campbell J, Bryant C, Lynch W (1998) The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 83:1561\u20131566","journal-title":"Cancer"},{"key":"0322_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/91.2.71","volume":"91","author":"Eastell","year":"1998","unstructured":"Eastell R, Boyle IT, Compston J, Cooper C, Fogelman I, Francis RM, Hosking DJ, Purdie DW, Ralston S, Reeve J, Reid DM, Russell RG, Stevenson JC (1998) Management of male osteoporosis: report of the UK Consensus Group. Q J Med 91:71\u201392","journal-title":"Q J Med"},{"key":"0322_CR12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","volume":"9","author":"Genant","year":"1994","unstructured":"Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, Van Kuijk C (1994) Universal standardization of dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Min Res 9:1503\u20131514","journal-title":"J Bone Min Res"},{"key":"0322_CR13","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1359\/jbmr.1997.12.8.1316","volume":"12","author":"Hanson","year":"1997","unstructured":"Hanson J (1997) Standardization of femur BMD. J Bone Min Res 12:1316\u20131317","journal-title":"J Bone Min Res"},{"key":"0322_CR14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0022-5347(05)67032-2","volume":"164","author":"Iversen","year":"2000","unstructured":"Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, Van Poppel H, Tammela TL, Chamberlain M, Carroll K, Melezinek I (2000) Bicalutamide ('Casodex') 150\u00a0mg monotherapy compared with castration in patients with non-metastatic locally advanced prostate cancer: 6.3\u00a0years' follow-up. J Urol 164:1579\u20131582","journal-title":"J Urol"},{"key":"0322_CR15","first-page":"932","volume":"22","author":"Jones","year":"1995","unstructured":"Jones G, Nguyen T, Sambrook PN, Kelly PJ, Eisman JA (1995) A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol 22:932\u2013936","journal-title":"J Rheumatol"},{"key":"0322_CR16","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1002\/jbmr.5650051112","volume":"5","author":"Kelly","year":"1990","unstructured":"Kelly TL (1990) Bone mineral density reference databases for American men and women. J Bone Min Res 5 (Suppl 1): S249","journal-title":"J Bone Min Res"},{"key":"0322_CR17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/PL00004149","volume":"7","author":"Lippuner","year":"1997","unstructured":"Lippuner K, von Overbeck J, Perrelet R, Bosshard H, Jaeger P (1997) Incidence and direct medical costs of hospitalisations due to osteoporotic fractures in Switzerland. Osteoporos Int 7:414\u2013425","journal-title":"Osteoporos Int"},{"key":"0322_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CCJr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468\u2013489","journal-title":"Osteoporos Int"},{"key":"0322_CR19","unstructured":"Lunar DPX Series Operator's Manual (1998) Lunar Corporation, Madison"},{"key":"0322_CR20","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1359\/jbmr.1997.12.11.1883","volume":"12","author":"Lunt","year":"1997","unstructured":"Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J, Dodenhof C, Falch JA, Masaryk P, Pols HA, Poor G, Reid DM, Scheidt-Nave C, Weber K, Varlow J, Kanis JA, O'Neill TW, Silman AJ (1997) Bone density variation and its effect on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS study. J Bone Min Res 12:1883\u20131894","journal-title":"J Bone Min Res"},{"key":"0322_CR21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0022-5347(01)61639-2","volume":"161","author":"Maillefert","year":"1999","unstructured":"Maillefert JF, Sibilia J, Michel F, Saussine C, Javier RM, Tavernier C (1999) Bone mineral density in men treated with synthetic gonadotrophin-releasing hormone agonists for prostatic carcinoma. J Urol 161:1219\u20131222","journal-title":"J Urol"},{"key":"0322_CR22","first-page":"etiology","volume":"LJ","author":"Melton","year":"1995","unstructured":"Melton LJ (1995) Epidemiology of fractures. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management, 2nd edn. Lippincott-Raven, Philadelphia, pp225\u2013247","journal-title":"Melton"},{"key":"0322_CR23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1359\/jbmr.1998.13.12.1915","volume":"13","author":"Melton","year":"1998","unstructured":"Melton LJ, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Min Res 13:1915\u20131923","journal-title":"J Bone Min Res"},{"key":"0322_CR24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01626603","volume":"5","author":"Randell","year":"1995","unstructured":"Randell A, Sambrook PN, Nguyen TV, Lapsley H, Jones G, Kelly PJ, Eisman JA (1995) Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporosis Int 5:427\u2013432","journal-title":"Osteoporosis Int"},{"key":"0322_CR25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1359\/jbmr.1997.12.1.24","volume":"12","author":"Ray","year":"1997","unstructured":"Ray NF, Chan JK, Thamer M, Melton LJ3rd (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Min Res 12:24\u201325","journal-title":"J Bone Min Res"},{"key":"0322_CR26","first-page":"196a","volume":"21","author":"Sieber","year":"2002","unstructured":"Sieber PR, Keiller DL, Kahnoski RJ, Garcia-Vargas JE, Gallo J, McFadden S (2002) Bone mineral density is maintained during bicalutamide ('Casodex') treatment. Proc Am Soc Clin Oncol 21:196a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"0322_CR27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/jbmr.5650101022","volume":"10","author":"Steiger","year":"1995","unstructured":"Steiger P (1995) Standardization of spine BMD measurements. J Bone Min Res 10:1602","journal-title":"J Bone Min Res"},{"key":"0322_CR28","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1016\/S0022-5347(01)61656-2","volume":"161","author":"Suzuki","year":"1999","unstructured":"Suzuki Y, Oishi Y, Aikawa K, Wada T, Yamazaki H, Hasegawa N, Aoki H, Shiono Y, Takasaka S, Akazawa K, Shibuya M, Onishi T, Yoshino Y (1999) The risk of osteoporosis after androgen deprivation in patients with prostatic carcinoma. J Urol 161 (Suppl 89): Abstract 1141","journal-title":"J Urol"},{"key":"0322_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO;2-3","volume":"79","author":"Townsend","year":"1997","unstructured":"Townsend MF, Sanders WH, Northway RO, Graham SDJr (1997) Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma. Cancer 79:545\u2013550","journal-title":"Cancer"},{"key":"0322_CR30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000019634","volume":"33","author":"Tyrrell","year":"1998","unstructured":"Tyrrell CJ, Kaisary AV, Iversen P, Anderson JB, Baert L, Tammela T, Chamberlain M, Webster A, Blackledge G (1998) A randomised comparison of 'Casodex' (bicalutamide) 150\u00a0mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol 33:447\u2013456","journal-title":"Eur Urol"},{"key":"0322_CR31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1994.tb02585.x","volume":"41","author":"Verhelst","year":"1994","unstructured":"Verhelst J, Denis L, Van Vliet P, Van Poppel H, Braeckman J, Van Cangh P, Mattelaer J, D'Hulster D, Mahler C (1994) Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer. Clin Endocrin 41:525\u2013530","journal-title":"Clin Endocrin"},{"key":"0322_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0090-4295(99)00301-5","volume":"54","author":"Wei","year":"1999","unstructured":"Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, Cooney KA (1999) Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology 54:607\u2013611","journal-title":"Urology"},{"key":"0322_CR33","unstructured":"World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. World Health Organization, Geneva"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-003-0322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-003-0322-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-003-0322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T12:57:00Z","timestamp":1722171420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-003-0322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,22]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0322"],"URL":"https:\/\/doi.org\/10.1007\/s00345-003-0322-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"type":"print","value":"0724-4983"},{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2003,3,22]]}}}